MARAVAI LIFESCIENCES HLDGS I's ticker is MRVI and the CUSIP is 56600D107. A total of 214 filers reported holding MARAVAI LIFESCIENCES HLDGS I in Q1 2023. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $106,420 | -7.6% | 10,642 | +14.9% | 0.00% | – |
| Q2 2023 | $115,126 | -6.9% | 9,262 | +5.0% | 0.00% | – |
| Q1 2023 | $123,610 | +19.9% | 8,823 | +22.5% | 0.00% | – |
| Q4 2022 | $103,062 | +10206.2% | 7,202 | +11706.6% | 0.00% | – |
| Q3 2022 | $1,000 | -66.7% | 61 | -15.3% | 0.00% | – |
| Q2 2022 | $3,000 | -62.5% | 72 | -69.7% | 0.00% | – |
| Q1 2022 | $8,000 | +100.0% | 238 | +153.2% | 0.00% | – |
| Q4 2021 | $4,000 | -50.0% | 94 | -48.4% | 0.00% | – |
| Q3 2021 | $8,000 | +60.0% | 182 | +43.3% | 0.00% | – |
| Q2 2021 | $5,000 | – | 127 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GTCR LLC | 21,681,033 | $764,690,000 | 24.22% |
| Nekton Capital Ltd. | 1,111,102 | $39,189,000 | 9.66% |
| Pavadi Capital LLC | 133,279 | $4,701,000 | 4.14% |
| Curi Wealth Management, LLC | 420,446 | $14,829,000 | 2.57% |
| Select Equity Group, L.P. | 19,100,056 | $673,659,000 | 2.18% |
| Ownership Capital B.V. | 4,205,521 | $148,329,000 | 1.96% |
| Beck Bode, LLC | 167,969 | $5,924,000 | 1.34% |
| Parkman Healthcare Partners LLC | 77,389 | $2,730,000 | 0.80% |
| STONE RUN CAPITAL, LLC | 55,285 | $1,960,000 | 0.72% |
| Champlain Investment Partners, LLC | 3,582,530 | $126,356,000 | 0.65% |